Günter U Höglinger, Irene Litvan, Nuno Mendonca, Deli Wang, Hui Zheng, Beatrice Rendenbach-Mueller, Hoi-Kei Lon, Ziyi Jin, Nahome Fisseha, Kumar Budur, Michael Gold, Davis Ryman, Hana Florian, ,
<h4>Background</h4>Progressive supranuclear palsy is a neurodegenerative disorder associated with tau protein aggregation. Tilavonemab (ABBV-8E12) is a monoclonal antibody that binds to the N-terminus of human tau. We assessed the safety and efficacy of tilavonemab for the treatment of progressive supranuclear palsy.<h4>Methods</h4>We did a phase 2, multicentre, randomised, placebo-controlled, double-blind study ... Read more >>
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):182-192]
Cited: 0 times
Ava Easton, Benedict D Michael,
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):172]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):165-166]
Cited: 0 times
Jonathan Graff-Radford, Keir X X Yong, Liana G Apostolova, Femke H Bouwman, Maria Carrillo, Bradford C Dickerson, Gil D Rabinovici, Jonathan M Schott, David T Jones, Melissa E Murray,
Most patients with Alzheimer's disease present with amnestic problems; however, a substantial proportion, over-represented in young-onset cases, have atypical phenotypes including predominant visual, language, executive, behavioural, or motor dysfunction. In the past, these individuals often received a late diagnosis; however, availability of CSF and PET biomarkers of Alzheimer's disease pathologies ... Read more >>
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):222-234]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):174]
Cited: 0 times
Jeroen T J M van Dijck, Erwin J O Kompanje, Paul J Nederkoorn, Wilco C Peul, Diederik W J Dippel,
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):170-171]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):162-163]
Cited: 0 times
Peter Hermann, Brian Appleby, Jean-Philippe Brandel, Byron Caughey, Steven Collins, Michael D Geschwind, Alison Green, Stephane Haïk, Gabor G Kovacs, Anna Ladogana, Franc Llorens, Simon Mead, Noriyuki Nishida, Suvankar Pal, Piero Parchi, Maurizio Pocchiari, Katsuya Satoh, Gianluigi Zanusso, Inga Zerr,
Sporadic Creutzfeldt-Jakob disease is a fatal neurodegenerative disease caused by misfolded prion proteins (PrP<sup>Sc</sup>). Effective therapeutics are currently not available and accurate diagnosis can be challenging. Clinical diagnostic criteria use a combination of characteristic neuropsychiatric symptoms, CSF proteins 14-3-3, MRI, and EEG. Supportive biomarkers, such as high CSF total tau, ... Read more >>
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):235-246]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):179-180]
Cited: 0 times
Andrea Sylvia Winkler, Matilde Leonardi, Benedict Daniel Michael, Foad Abd-Allah, William Carroll, Alla Guekht, ,
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):171-172]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):163-165]
Cited: 0 times
Alex Iranzo, Graham Fairfoul, Anutra Chumbala Na Ayudhaya, Monica Serradell, Ellen Gelpi, Isabel Vilaseca, Raquel Sanchez-Valle, Carles Gaig, Joan Santamaria, Eduard Tolosa, Renata L Riha, Alison J E Green,
<h4>Background</h4>Isolated rapid-eye-movement (REM) sleep behaviour disorder (IRBD) can be part of the prodromal stage of the α-synucleinopathies Parkinson's disease and dementia with Lewy bodies. Real-time quaking-induced conversion (RT-QuIC) analysis of CSF has high sensitivity and specificity for the detection of misfolded α-synuclein in patients with Parkinson's disease and dementia with ... Read more >>
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):203-212]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):174]
Cited: 0 times
Michel Shamy, Brian Dewar, Naomi Niznick, Stuart Nicholls, Dar Dowlatshahi,
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):170]
Cited: 0 times
The Lancet Neurology,
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):161]
Cited: 0 times
Dominic P J Howard, Liam Gaziano, Peter M Rothwell, ,
<h4>Background</h4>There is uncertainty around which patients with asymptomatic carotid stenosis should be offered surgical intervention. Although stroke rates were unrelated to the degree of stenosis in the medical-treatment-only groups in previous randomised trials, this could simply reflect recruitment bias and there has been no systematic analysis of a stenosis-risk association ... Read more >>
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):193-202]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):173]
Cited: 0 times
Massimiliano Todisco, Enrico Alfonsi, Sebastiano Arceri, Giulia Bertino, Carlo Robotti, Michele Albergati, Matteo Gastaldi, Cristina Tassorelli, Giuseppe Cosentino,
Lancet Neurol (The Lancet. Neurology)
[2021, 20(3):169-170]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, :]
Cited: 0 times
Mikael Mazighi, Sebastien Richard, Bertrand Lapergue, Igor Sibon, Benjamin Gory, Jerome Berge, Arturo Consoli, Julien Labreuche, Jean-Marc Olivot, Joseph Broderick, Alain Duhamel, Emmanuel Touze, Adnan I Qureshi, Amélie Yavchitz, Simon Escalard, Jean-Philippe Desilles, Hocine Redjem, Stanislas Smajda, Robert Fahed, Solène Hébert, Benjamin Maïer, François Delvoye, Perrine Boursin, Malek Ben Maacha, Michael Obadia, Candice Sabben, Raphael Blanc, Julien Savatovsky, Michel Piotin, ,
<h4>Background</h4>High systolic blood pressure after successful endovascular therapy for acute ischaemic stroke is associated with increased risk of intraparenchymal haemorrhage. However, no randomised controlled trials are available to guide optimal management. We therefore aimed to assess whether an intensive systolic blood pressure target resulted in reduced rates of intraparenchymal haemorrhage ... Read more >>
Lancet Neurol (The Lancet. Neurology)
[2021, :]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, :]
Cited: 0 times
Kjersti Grøtta Vetvik, E Anne MacGregor,
The term menstrual migraine refers to migraine that is associated with menstruation by more than chance, but it does not define pathophysiology. Menstrual migraine affects about 20-25% of female migraineurs in the general population, and 22-70% of patients presenting to headache clinics. In women diagnosed with menstrual migraine, perimenstrual migraine ... Read more >>
Lancet Neurol (The Lancet. Neurology)
[2021, :]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, :]
Cited: 0 times
Lancet Neurol (The Lancet. Neurology)
[2021, 20(2):e2]
Cited: 0 times
Liesbeth Aerts, Elsa Lauwers, Bart De Strooper,
Lancet Neurol (The Lancet. Neurology)
[2021, 20(2):90]
Cited: 0 times